Frankfurt - Delayed Quote EUR
Heidelberg Pharma AG (HPHA.F)
As of October 18 at 2:18 PM GMT+2. Market Open.
Research Analysis
Revenue vs. Earnings
Revenue 1.19M
Earnings -5.59M
Analyst Price Targets
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Aug 2024) | Next Qtr. (Nov 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Aug 2024) | Next Qtr. (Nov 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 11.5M | 15M |
| Low Estimate | -- | -- | 11.5M | 15M |
| High Estimate | -- | -- | 11.5M | 15M |
| Year Ago Sales | -- | -- | 9.86M | 11.5M |
| Sales Growth (year/est) | -- | -- | 16.60% | 30.40% |
Earnings History
| CURRENCY IN USD | |
|---|---|
| EPS Est. | -- |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Aug 2024) | Next Qtr. (Nov 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | -0.59 | -0.13 |
| 30 Days Ago | 0 | 0 | -0.59 | -0.13 |
| 60 Days Ago | 0 | 0 | -0.59 | -0.13 |
| 90 Days Ago | 0 | 0 | -0.59 | -0.13 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Aug 2024) | Next Qtr. (Nov 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HPHA.F | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.80% |
| Next Qtr. | -- | -- | -- | 8.00% |
| Current Year | -- | -- | -- | 2.50% |
| Next Year | -- | -- | -- | 13.10% |
| Next 5 Years (per annum) | -10.50% | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
9EN.F Pharvaris N.V.
18.80
-1.05%
UR9.SG Clinuvel Pharmaceuticals Ltd
9.11
0.00%
MDG1.DE Medigene AG
1.8720
+0.11%
MOLN Molecular Partners AG
4.8700
-2.21%
CLRPF Clarity Pharmaceuticals Ltd
4.5520
0.00%
PEPG PepGen Inc.
8.94
+0.79%
IKNA Ikena Oncology, Inc.
1.7100
0.00%
AVBP ArriVent BioPharma, Inc.
29.16
+0.59%
TLPPF Telix Pharmaceuticals Limited
14.80
+0.07%
PHVS Pharvaris N.V.
21.20
-0.24%